Stocks

The table gives an overview of all stocks, alphabetically sorted.
 AB INBEV ABI Jan 18, 2021 57.08 +0.60   
 ABO-Group ABO Jan 18, 2021 3.88 -3.00   
 Acacia Pharma Group Plc ACPH Jan 18, 2021 2.94 +2.61   
 Accentis S.A. ACCB Jan 18, 2021 0.05 0.00   
 Ackermans & van Haaren NV ACKB Jan 18, 2021 130.20 +0.54   
 Aedifica SA AED Jan 18, 2021 97.20 +0.93   
 Ageas AGS Jan 18, 2021 45.42 -0.48   
 AGFA-Gevaert NV AGFB Jan 18, 2021 3.98 +0.38   
 AHOLD DEL AD Jan 18, 2021 23.95 -3.66   
 Antares Certificates ANT Jan 18, 2021 46.58 -0.04   
 APERAM APAM Jan 18, 2021 35.86 +0.76   
 Argen X SE ARGX Jan 18, 2021 231.20 -0.09   
 Ascencio Sca ASC Jan 18, 2021 48.10 +0.10   
 ASIT biotech SA ASIT Jan 18, 2021 0.36 +3.99   
 Assicurazioni Generali SpA GEN Jan 18, 2021 14.52 -1.43   
 Atenor ATEB Jan 18, 2021 56.20 -0.71   
 AVANTIUM AVTX Jan 18, 2021 6.20 -3.13   
 Balta Group N.V. BALTA Jan 18, 2021 2.09 -4.13   
 Banco Bilbao Vizcaya Argentaria SA BBV Jan 18, 2021 4.06 0.00   
 Banco Santander SA SANTA Jan 18, 2021 2.69 +0.04   
 Banimmo BANI Jan 18, 2021 2.68 -2.19   
 Banque Nationale de Belgique BNB Jan 18, 2021 1 790.00 +0.28   
 Barco NV BAR Jan 18, 2021 18.52 +1.67   
 Basilix BAS Jan 18, 2021 12.11 0.00   
 Beaulieu Av Certificates BEAB Jan 18, 2021 11.00 +4.76   
 Befimmo SA BEFB Jan 18, 2021 36.30 -0.14   
 Bel20 BEL20 Jan 18, 2021 3 745.33 +0.80   
 Belreca - Belgian Resources and Capital Company BELR Jan 18, 2021 114.00 0.00   
 Beluga BELU Jan 18, 2021 2.76 0.00   
 Biocartis Group NV BCART Jan 18, 2021 4.75 +0.96   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK